Neurobiological Mechanisms Underlying Psychological Dysfunction After Brain Injuries
Open Access
Abstract
Despite the presentation of similar psychological symptoms, psychological dysfunction secondary to brain injury exhibits markedly lower treatment efficacy compared to injury-independent psychological dysfunction. This gap remains evident, despite extensive research efforts. This review integrates clinical and preclinical evidence to provide a comprehensive overview of the neurobiological mechanisms underlying neuropsychological disorders, focusing on the role of key brain regions in emotional regulation across various forms of brain injuries. It examines therapeutic interventions and mechanistic targets, with the primary goal of identifying pathways for targeted treatments. The review highlights promising therapeutic avenues for addressing injury-associated psychological dysfunction, emphasizing Nrf2, neuropeptides, and nonpharmacological therapies as multi-mechanistic interventions capable of modulating upstream mediators to address the complex interplay of factors underlying psychological dysfunction in brain injury. Additionally, it identifies sexually dimorphic factors as potential areas for further exploration and advocates for detailed investigations into sex-specific patterns to uncover additional contributors to these disorders. Furthermore, it underscores significant gaps, particularly the inadequate consideration of interactions among causal factors, environmental influences, and individual susceptibilities. By addressing these gaps, this review provides new insights and calls for a paradigm shift toward a more context-specific and integrative approach to developing targeted therapies for psychological dysfunction following brain injuries.Keywords
Funding Information
- U.S. Army Medical Research Acquisition Activity (HT9425-24-1-1017)
- Feinstein Institutes for Medical Research (HT9425-24-1-1017)
This publication has 224 references indexed in Scilit:
- Pharmacological and psychological interventions for depression in people with tuberculosisCochrane Database of Systematic Reviews, 2021
- Pharmacological interventions for self-harm in adultsCochrane Database of Systematic Reviews, 2021
- Association of Selective Serotonin Reuptake Inhibitor Use After Intracerebral Hemorrhage With Hemorrhage Recurrence and Depression SeverityJAMA Neurology, 2020
- Neuroendocrine function and associated mental health outcomes following mild traumatic brain injury in OEF‐deployed service membersJournal of Neuroscience Research, 2020
- Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and InterpretationClinical Pharmacology & Therapeutics, 2019
- Reflections on Neuroprotection Research and the Path Toward Clinical Success2017
- Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic strokePsychopharmacology, 2015
- A limited number of prescribed drugs account for the great majority of drug-drug interactionsEuropean Journal of Clinical Pharmacology, 2014
- Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United StatesInternational Journal of Methods in Psychiatric Research, 2012
- Apoptotic and behavioral sequelae of mild brain trauma in miceJournal of Neuroscience Research, 2007